Bizzarely patterned erythema and papules in a 39-year-old man;Bizarr konfiguriertes erythem und papeln bei einem 39-jährigen mann

Hautarzt

Volumn 53, Issue 7, 2002, Pages 495-498

  Emmert, S ^a   Bertsch, H P ^b   Zutt, M ^b   Haenssle, H ^b   Hallermann, C ^b   Kretschmer, L ^b   Neumann, C ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT; BUSERELIN; DOCETAXEL; DOXORUBICIN; GONADORELIN DERIVATIVE; TAMOXIFEN; CA 15-3 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TUMOR MARKER;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST DISEASE; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MALE BREAST; MASTECTOMY; RISK FACTOR; SKIN BIOPSY; BIOPSY; BREAST TUMOR; CANCER STAGING; ERYTHEMA; ERYTHEMATOSQUAMOUS SKIN DISEASE; METASTASIS; PARANEOPLASTIC SYNDROME; PATHOLOGY; PROGNOSIS; SKIN; SKIN TUMOR;

ADULT; BIOPSY; BREAST NEOPLASMS, MALE; CA-15-3 ANTIGEN; ERYTHEMA; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; PARANEOPLASTIC SYNDROMES; PROGNOSIS; RECEPTOR, ERBB-2; SKIN; SKIN DISEASES, PAPULOSQUAMOUS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036632343     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-002-0371-7     Document Type: Article

References (16)

1. American Joint Committee on Cancer (1997). In: Beahrs O, Henson D, Hutter R, Kennedy B (eds) Manual for staging of cancer. (5 edn). Lippincott JB, Philadelphia.
2. Andre S, Fonseca I, Pinto AE, Cardoso P, Pereira T, Soares J (2001) Male breast cancer - a reappraisal of clinical and biologic indicators of prognosis. Acta Oncol 40:472-478
3. Cunha F, Andre S, Soares J (1990) Morphology of male breast carcinoma in the evaluation of prognosis. Pathol Res Pract 186:745-750
4. Donegan WL, Redlich PN (1996) Breast cancer in men. Surg Clin North Am 76:343-363
5. Ewertz M, Holmberg L, Tretli S, Pedersen BV, Kristensen A (2001) Risk factors for male breast cancer - a case-control study from Scandinavia. Acta Oncol 40:467-471
6. Geageau A (2001) Diagnose und Behandlung der Gynäkomastie und des männlichen Mammakarzinoms. Zästh op Derm 2:24-30
7. Gennari R, Renne G, Travaini L, Bassi F, Zurrida S (2001) Sentinel node biopsy in male breast cancer: future standard treatment? Eur J Surg 167:461-462
8. Gough DB, Donohue JH, Evans MM, Pernicone PJ, Wold LE, Naessens JM, O'Brien PC (1993) A 50-year experience of male breast cancer: is outcome changing? Surg Oncol 2:325-333
9. Joshi MG, Lee AK, Loda M, Camus MG, Pedersen C, Heatley GJ, Hughes KS (1996) Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 77:490-498
10. Kim JH, Benson PM, Beard JS, Skelton HG3rd (1998) Male breast carcinoma with extensive metastases to the skin. J Am Acad Dermatol 38:995-996
11. Lookingbill DP, Spangler N, Sexton FM (1990) Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients. J Am Acad Dermatol 22:19-26
12. Morris PR, Prstojevich SJ, Hedayati P (2001) Male breast cancer with maxillofacial metastasis: case report. J Oral Maxillofac Surg 59:578-580
13. Raton JA, Bilbao I, Gardeazabal J, Alvarez S, Vicente JM, Gonzalez R, Mitxelena J, Diaz-Perez JL (1998) Skin involvement in male breast carcinoma. Arch Dermatol 134:517-518
14. Sandler B, Carman C, Perry RR (1994) Cancer of the male breast. Am Surg 60:816-820
15. Stuntz M, Yamini D, Moss J, Klein S, Khalkhali I (2000) Bilateral Orbital Metastases as the Presenting Finding in a Male Patient with Breast Cancer: A Case Report and Review of the Literature. Breast J 6:204-208
16. Willsher PC, Leach IH, Ellis IO, Bell JA, Elston CW, Bourke JB, Blamey RW, Robertson JF (1997) Male breast cancer: pathological and immunohistochemical features. Anticancer Res 17:2335-2338